Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

NCT05765396 is registered in ClinicalTrials.gov with The Geneva Foundation as lead sponsor.

NCT NCT05765396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05765396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Lead sponsor
The Geneva Foundation
Phase
Observational
Overall status
Completed
Start date
May 15, 2023
Completion date
March 30, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid-19, covid-19 ards, covid-19 pneumonia, influenza, respiratory infection, rsv infection, sars-cov-2 virus